Biocon To Launch Approved Generic Liraglutide ‘Expeditiously’ In India
The Firm Believes GLP-1s To Be The Key Drivers Of Its Future Growth
Marking its first vertically integrated GLP-1 product in India, Biocon said the generic liraglutide was approved under CDSCO’s Rule 101, which recognizes approvals from “established and referenced serious regulatory authorities.”
